145 related articles for article (PubMed ID: 38494680)
1. CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells.
Liu S; Chen X; Zhang L; Lu B
Cancer Biol Ther; 2024 Dec; 25(1):2329372. PubMed ID: 38494680
[TBL] [Abstract][Full Text] [Related]
2. POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway.
Yang R; Wang M; Zhang G; Li Y; Wang L; Cui H
Cell Death Dis; 2021 Apr; 12(5):433. PubMed ID: 33931589
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival.
Nalairndran G; Hassan Abdul Razack A; Mai CW; Fei-Lei Chung F; Chan KK; Hii LW; Lim WM; Chung I; Leong CO
J Cell Mol Med; 2020 Oct; 24(20):12188-12198. PubMed ID: 32926495
[TBL] [Abstract][Full Text] [Related]
4. Succinylation of CTBP1 mediated by KAT2A suppresses its inhibitory activity on the transcription of CDH1 to promote the progression of prostate cancer.
Zhou J; Yan X; Liu Y; Yang J
Biochem Biophys Res Commun; 2023 Apr; 650():9-16. PubMed ID: 36764210
[TBL] [Abstract][Full Text] [Related]
5. KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer.
Zhang C; Huang Z
Mol Biotechnol; 2023 Jun; ():. PubMed ID: 37294531
[TBL] [Abstract][Full Text] [Related]
6. Stomatin-Mediated Inhibition of the Akt Signaling Axis Suppresses Tumor Growth.
Rahman NIA; Sato A; Tsevelnorov K; Shimizu A; Komeno M; Ahmat Amin MKB; Molla MR; Soh JEC; Nguyen LKC; Wada A; Kawauchi A; Ogita H
Cancer Res; 2021 May; 81(9):2318-2331. PubMed ID: 33757977
[TBL] [Abstract][Full Text] [Related]
7. Binding of
Zhang Y; Hu B; Li Y; Deng T; Xu Y; Lei J; Zhou J
Autophagy; 2020 Sep; 16(9):1697-1710. PubMed ID: 31885313
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis.
Ding Y; Chi H; Shao J; Shi T; Yu H; Wang X; Wang X
Clin Transl Med; 2022 Feb; 12(2):e676. PubMed ID: 35172032
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP.
Dang Y; Chen J; Feng W; Qiao C; Han W; Nie Y; Wu K; Fan D; Xia L
Theranostics; 2020; 10(8):3833-3848. PubMed ID: 32206125
[No Abstract] [Full Text] [Related]
10. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer.
Li X; Zhang C; Zhao T; Su Z; Li M; Hu J; Wen J; Shen J; Wang C; Pan J; Mu X; Ling T; Li Y; Wen H; Zhang X; You Q
J Exp Clin Cancer Res; 2020 Aug; 39(1):172. PubMed ID: 32859246
[TBL] [Abstract][Full Text] [Related]
11. A new and important relationship between miRNA-147a and PDPK1 in radiotherapy.
Wang LJ; Li NN; Xu SJ; Zhang F; Hao MH; Yang XJ; Cai XH; Qiu PY; Ji HL; Xu P
J Cell Biochem; 2018 Apr; 119(4):3519-3527. PubMed ID: 29144017
[TBL] [Abstract][Full Text] [Related]
12. Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells.
Li D; Mullinax JE; Aiken T; Xin H; Wiegand G; Anderson A; Thorgeirsson S; Avital I; Rudloff U
BMC Cancer; 2018 Jul; 18(1):772. PubMed ID: 30064387
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma.
Chinen Y; Kuroda J; Shimura Y; Nagoshi H; Kiyota M; Yamamoto-Sugitani M; Mizutani S; Sakamoto N; Ri M; Kawata E; Kobayashi T; Matsumoto Y; Horiike S; Iida S; Taniwaki M
Cancer Res; 2014 Dec; 74(24):7418-29. PubMed ID: 25269480
[TBL] [Abstract][Full Text] [Related]
14. miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells.
Han T; Wu N; Wang Y; Shen W; Zou J
Int J Mol Med; 2019 Mar; 43(3):1441-1451. PubMed ID: 30664182
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.
Maegawa S; Chinen Y; Shimura Y; Tanba K; Takimoto T; Mizuno Y; Matsumura-Kimoto Y; Kuwahara-Ota S; Tsukamoto T; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
Exp Hematol; 2018 Mar; 59():72-81.e2. PubMed ID: 29287939
[TBL] [Abstract][Full Text] [Related]
16. CPT1A-mediated succinylation of S100A10 increases human gastric cancer invasion.
Wang C; Zhang C; Li X; Shen J; Xu Y; Shi H; Mu X; Pan J; Zhao T; Li M; Geng B; Xu C; Wen H; You Q
J Cell Mol Med; 2019 Jan; 23(1):293-305. PubMed ID: 30394687
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
Zhang D; Yang XJ; Luo QD; Xue L; Chong T
Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of the Hedgehog and PDPK1-Akt pathways in the growth and migration of small-cell lung cancer.
Tang N; Hu B; Zhang Y; Chen Z; Yu R
J Int Med Res; 2021 May; 49(5):3000605211016562. PubMed ID: 34038205
[TBL] [Abstract][Full Text] [Related]
19. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.
Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS
J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation of PDPK1 Is required to maintain glycolysis-dependent CD4 T-cell homeostasis.
Sun F; Wang FX; Zhu H; Yue TT; Yang CL; Luo JH; Luo X; Zhou HF; Rong SJ; Lu WY; Zhou Q; Yang P; Xiong F; Liu YJ; Yan T; Liao YF; Zhang S; Wang CY
Cell Death Dis; 2022 Feb; 13(2):181. PubMed ID: 35210408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
